Clavio, Marino
 Distribuzione geografica
Continente #
EU - Europa 2.011
AS - Asia 125
SA - Sud America 25
NA - Nord America 23
AF - Africa 2
Totale 2.186
Nazione #
IT - Italia 2.006
SG - Singapore 50
CN - Cina 38
VN - Vietnam 28
US - Stati Uniti d'America 20
BR - Brasile 18
BD - Bangladesh 3
RU - Federazione Russa 3
AR - Argentina 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
GB - Regno Unito 1
ID - Indonesia 1
IN - India 1
IQ - Iraq 1
KW - Kuwait 1
MX - Messico 1
PT - Portogallo 1
PY - Paraguay 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.186
Città #
Genoa 847
Genova 767
Rapallo 218
Vado Ligure 158
Beijing 16
Singapore 14
Ashburn 10
Ho Chi Minh City 6
Hanoi 5
Bordighera 4
Perugia 3
Catania 2
Denver 2
Haiphong 2
Milan 2
Ninh Bình 2
Trieste 2
Abu Dhabi 1
Algiers 1
Aracaju 1
Araruama 1
As Sālimīyah 1
Atlanta 1
Barquisimeto 1
Barretos 1
Bertioga 1
Biên Hòa 1
Brooklyn 1
Bắc Ninh 1
Caicó 1
Campina Grande do Sul 1
Chapada Gaúcha 1
Chennai 1
Colina 1
Corrientes 1
Curitiba 1
Da Nang 1
Del Viso 1
Haikou 1
Hortolândia 1
Istanbul 1
Itu 1
Izhevsk 1
Johannesburg 1
Lambaré 1
Lorena 1
Macapá 1
Maracaibo 1
Maringá 1
Matosinhos Municipality 1
Mexico City 1
Milltown 1
New York 1
Palermo 1
Paraty 1
Phoenix 1
Phúc Yên 1
Phủ Lý 1
Pindamonhangaba 1
Poplar 1
Pouso Alegre 1
Quito 1
San Jose 1
Santiago de los Caballeros 1
Sarapul 1
Sátiro Dias 1
São Bernardo do Campo 1
Tianjin 1
Toronto 1
Vinh 1
Vĩnh Long 1
Vĩnh Tường 1
Yaroslavl 1
Totale 2.116
Nome #
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis 188
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 187
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 185
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 176
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas 173
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 172
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives 171
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 156
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 154
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 150
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis 123
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 113
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 96
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 66
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice 49
Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature 47
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 42
Totale 2.248
Categoria #
all - tutte 8.024
article - articoli 8.024
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 0 0 0 0 0 21 2 21 15 19 11 24
2021/2022154 3 2 13 20 15 14 8 27 15 11 8 18
2022/2023260 22 27 3 26 49 28 1 14 34 19 31 6
2023/2024212 11 15 3 23 12 47 24 39 4 7 13 14
2024/2025533 13 29 13 31 37 51 67 124 15 26 62 65
2025/2026421 117 18 40 104 107 35 0 0 0 0 0 0
Totale 2.248